Tuo Y - Search Results

1

Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children.

Wang Y, Sun D, Mei Y, Wu S, Li X, Li S, Wang J, Gao L, Xu H, Tuo Y. Wang Y, et al. Among authors: tuo y. Pharmaceutics. 2022 May 11;14(5):1033. doi: 10.3390/pharmaceutics14051033. Pharmaceutics. 2022. PMID: 35631619 Free PMC article.

2

Understanding inter-individual variability in pharmacokinetics/pharmacodynamics of aripiprazole in children with tic disorders: Individualized administration based on physiological development and CYP2D6 genotypes.

Xin Y, Gao L, Tuo Y, Nie G, Mei Y, Chen C, Wang J, Li S, Sun D, Qian Q, Fu Y, Wang Y, Liu Z. Xin Y, et al. Among authors: tuo y. Front Pharmacol. 2022 Dec 2;13:1048498. doi: 10.3389/fphar.2022.1048498. eCollection 2022. Front Pharmacol. 2022. PMID: 36532742 Free PMC article.

3

How to handle a missed or delayed dose of lacosamide in pediatric patients with epilepsy? a mode-informed individual dosing.

Wang J, Mei Y, Liang S, Li SC, Chen C, Nie G, Tuo YL, Sun D, Wang Y. Wang J, et al. Among authors: tuo yl. Epilepsy Behav. 2024 Feb;151:109601. doi: 10.1016/j.yebeh.2023.109601. Epub 2024 Jan 8. Epilepsy Behav. 2024. PMID: 38194771

4

Population pharmacokinetics and dosing optimization of perampanel in children with epilepsy: A real-world study.

Li S, Yi J, Tuo Y, Nie G, Wang J, Wang Y, Sun D, Liu Z. Li S, et al. Among authors: tuo y. Epilepsia. 2024 Jun;65(6):1687-1697. doi: 10.1111/epi.17954. Epub 2024 Apr 4. Epilepsia. 2024. PMID: 38572689

5

Anti-inflammatory and metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor-bearing mice.

Tuo Y, Zhang Z, Tian C, Hu Q, Xie R, Yang J, Zhou H, Lu L, Xiang M. Tuo Y, et al. J Leukoc Biol. 2020 Jul;108(1):215-228. doi: 10.1002/JLB.3MA0120-578R. Epub 2020 Jan 29. J Leukoc Biol. 2020. PMID: 31994797

6

Lian-Qu formula treats metabolic syndrome via reducing fat synthesis, insulin resistance and inflammation.

Huang R, Wang B, He J, Zhang Z, Xie R, Li S, Li Q, Tian C, Tuo Y, Zheng R, Chen W, Xiang M. Huang R, et al. Among authors: tuo y. J Ethnopharmacol. 2023 Apr 24;306:116060. doi: 10.1016/j.jep.2022.116060. Epub 2022 Dec 17. J Ethnopharmacol. 2023. PMID: 36535333

7

The Role of CARD9 in Metabolic Diseases.

Tian C, Tuo YL, Lu Y, Xu CR, Xiang M. Tian C, et al. Among authors: tuo yl. Curr Med Sci. 2020 Apr;40(2):199-205. doi: 10.1007/s11596-020-2166-4. Epub 2020 Apr 26. Curr Med Sci. 2020. PMID: 32337681 Review.

8

Effects of kinsenoside, a potential immunosuppressive drug for autoimmune hepatitis, on dendritic cells/CD8⁺ T cells communication in mice.

Xiang M, Liu T, Tan W, Ren H, Li H, Liu J, Cao H, Cheng Q, Liu X, Zhu H, Tuo Y, Wang J, Zhang Y. Xiang M, et al. Among authors: tuo y. Hepatology. 2016 Dec;64(6):2135-2150. doi: 10.1002/hep.28825. Epub 2016 Oct 28. Hepatology. 2016. PMID: 27639182

9

Immune and Metabolic Regulation Mechanism of Dangguiliuhuang Decoction against Insulin Resistance and Hepatic Steatosis.

Cao H, Tuo L, Tuo Y, Xia Z, Fu R, Liu Y, Quan Y, Liu J, Yu Z, Xiang M. Cao H, et al. Among authors: tuo l, tuo y. Front Pharmacol. 2017 Jul 7;8:445. doi: 10.3389/fphar.2017.00445. eCollection 2017. Front Pharmacol. 2017. PMID: 28736524 Free PMC article.

10

Acceleration of pancreatic tumorigenesis under immunosuppressive microenvironment induced by Reg3g overexpression.

Liu X, Zhou Z, Cheng Q, Wang H, Cao H, Xu Q, Tuo Y, Jiang L, Zou Y, Ren H, Xiang M. Liu X, et al. Among authors: tuo y. Cell Death Dis. 2017 Sep 7;8(9):e3033. doi: 10.1038/cddis.2017.424. Cell Death Dis. 2017. PMID: 28880262 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters